FDA approves first maternal RSV vaccine to help protect infants
(NEW YORK) -- The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be given during late pregnancy to reduce the risk of severe RSV infection among newborns.However, the... Read More.